... stock from the most recent broker reports is 14.14 The stock increased +0.00% (+0.00) during the last days session, reaching 23.99 and roughly 0 shares were bought or sold by traders. ARIAD Pharmaceuticals, Inc. …
Trades
Aria is its Wi-Fi connected scale that tracks weight ... Samsung and Xiaomi. Pay Attention To How The Stock Reacts To The News: From …
Fitbit
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced it has entered into a definitive agreement to be …
NASDAQ
11 at MGM, however, that’s like an almost 10% stock decline there for a …
Las Vegas
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock is having a field day as rumors regarding a buyout continue to swirl. Japanese company Takeda Pharmaceutical Co Ltd is reportedly considering acquiring Ariad as part …
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research note issued on Thursday. The firm presently has a $27.00 target price on …
Australian Recording Industry Association
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) – Stock analysts at Leerink Swann issued their FY2019 earnings per share (EPS) estimates for shares of ARIAD Pharmaceuticals in a research report issued to clients and …
Australian Recording Industry Association
Ariad stock rocketed nearly 73% on Jan. 9 when the company announced it had reached an agreement to be acquired, an announcement timed to coincide with the JPMorgan Healthcare Conference in San Francisco, …
Royal Bank of Canada
Over the last few years, Ariad has been attempting to sell itself to a larger biopharmaceutical peer, but a deal failed to go through in the past because of management's internal valuation of the company's clinical and …